LEADER 03571nam  22005055  450 
001 9910300324703321
005 20200704164826.0
010   $a3-319-57760-3
024 7 $a10.1007/978-3-319-57760-9
035   $a(CKB)4100000000882219
035   $a(DE-He213)978-3-319-57760-9
035   $a(MiAaPQ)EBC5117955
035   $z(PPN)258872055
035   $a(PPN)220127514
035   $a(EXLCZ)994100000000882219
100   $a20171031d2018      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBrain Metastases $eAdvanced Neuroimaging /$fby Mikhail Dolgushin, Valery Kornienko, Igor Pronin
205   $a1st ed. 2018.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018.
215   $a1 online resource (XIII, 469 p. 480 illus., 80 illus. in color.)
311   $a3-319-57758-1 
320   $aIncludes bibliographical references and index.
327   $aClinical and Prognostic Value of Neuroimaging in Metastatic Brain Tumors -- Clinical Evaluation and Neuroimaging Methods -- MR-Characteristics of Brain Metastases of Different Primary Tumors -- CT-Perfusion in Diagnostic of Brain Metastases -- PET Evidence of Cancer throughout the Body and Brain -- Differential Diagnosis between Primary and Secondary Brain Tumors.
330   $aThis book describes the role of advanced neuroimaging techniques in characterizing the changes in tissue structure in patients with brain metastases. On a large number of newly recognized CT, MRI, and PET characteristics of brain metastases from different primary tumors are highlighted, thereby elucidating the potential differential diagnostic role of CT perfusion imaging, MR spectroscopy, MR diffusion-weighted imaging, MR susceptibility-weighted imaging, and PET with different radiopharmaceuticals. For example, the different manifestations of metastases of melanoma, renal cell carcinoma, and ovarian cancer on MRI and CT perfusion imaging are described, and the role of MR susceptibility-weighted imaging in the differential diagnosis of glioblastoma multiforme and metastatic tumors is clarified. Metastases of colon cancer have shown a special manifestation on T2 weighted images. The book also presents novel findings regarding pathogenesis and tumor biology and describes qualitative and quantitative changes in tumor tissue and alterations in brain white matter due to surrounding tumor growth. Neuroradiologists and others, including neurosurgeons, neurologists, and nuclear medicine physicians, will find that this book offers a fascinating insight into the ways in which newly available data on structural, hemodynamic, and metabolic changes are enriching the neuroimaging of brain metastases.
606   $aNeuroradiology
606   $aNeurosurgery
606   $aNeuroradiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H2903X
606   $aNeurosurgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H39000
615  0$aNeuroradiology.
615  0$aNeurosurgery.
615 14$aNeuroradiology.
615 24$aNeurosurgery.
676   $a616.0757
700   $aDolgushin$b Mikhail$4aut$4http://id.loc.gov/vocabulary/relators/aut$0784174
702   $aKornienko$b Valery$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aPronin$b Igor$4aut$4http://id.loc.gov/vocabulary/relators/aut
906   $aBOOK
912   $a9910300324703321
996   $aBrain Metastases$91923106
997   $aUNINA